HEADER HYDROLASE 18-AUG-04 1W6H TITLE NOVEL PLASMEPSIN II-INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMEPSIN 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ASPARTIC PROTEASE, ASPARTIC HEMOGLOBINASE II, PFAPD; COMPND 5 EC: 3.4.23.39; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 5833; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MALARIA, DRUG, ASPARTIC PROTEASE, PLASMEPSIN, HYDROLASE, GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.LINDBERG,P.-O.JOHANSSON,A.ROSENQUIST,I.KVARNSTROEM,L.VRANG, AUTHOR 2 B.SAMUELSSON,T.UNGE REVDAT 4 23-OCT-24 1W6H 1 REMARK REVDAT 3 17-JAN-18 1W6H 1 REMARK REVDAT 2 24-FEB-09 1W6H 1 VERSN REVDAT 1 05-JUL-06 1W6H 0 JRNL AUTH J.LINDBERG,P.-O.JOHANSSON,A.ROSENQUIST,I.KVARNSTROEM, JRNL AUTH 2 L.VRANG,B.SAMUELSSON,T.UNGE JRNL TITL STRUCTURAL STUDY OF A NOVEL INHIBITOR WITH BULKY P1 SIDE JRNL TITL 2 CHAIN IN COMPLEX WITH PLASMEPSIN II -IMPLICATIONS FOR DRUG JRNL TITL 3 DESIGN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 84.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 25914 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1377 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.24 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1732 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 98 REMARK 3 BIN FREE R VALUE : 0.3020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5148 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.61000 REMARK 3 B22 (A**2) : -2.41000 REMARK 3 B33 (A**2) : -0.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.12000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.546 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.259 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.183 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.347 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5446 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4808 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7412 ; 1.582 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11272 ; 1.142 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 656 ; 7.165 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 850 ; 0.148 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5992 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1074 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1041 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5670 ; 0.241 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3248 ; 0.091 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 255 ; 0.175 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 34 ; 0.149 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 127 ; 0.212 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 18 ; 0.118 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3272 ; 0.952 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5330 ; 1.749 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2174 ; 2.118 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2082 ; 3.423 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 1W6H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1290020816. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I711 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.13375 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25914 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 85.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.80700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYTIC ACTIVITY: HYDROLYSIS OF THE BONDS LINKING REMARK 400 CERTAIN HYDROPHOBIC RESIDUES IN HEMOGLOBIN OR GLOBIN. REMARK 400 ALSO CLEAVES SMALL MOLECULES SUBSTRATES SUCH AS REMARK 400 ALA-LEU-GLU-ARG-THR-PHE-|-PHE(NO(2))-SER-PHE-PRO-THR. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A -1 REMARK 465 GLY A 0 REMARK 465 PRO A 240 REMARK 465 PHE A 241 REMARK 465 LEU A 242 REMARK 465 PRO A 243 REMARK 465 LEU B -1 REMARK 465 GLY B 0 REMARK 465 PRO B 240 REMARK 465 PHE B 241 REMARK 465 LEU B 242 REMARK 465 PRO B 243 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 225 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP A 303 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 316 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP B 19 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP B 137 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 225 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 279 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP B 303 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 69 -73.52 -142.57 REMARK 500 LEU A 126 21.77 -146.62 REMARK 500 LYS A 163 -54.83 -128.70 REMARK 500 LEU A 191 -84.13 -141.88 REMARK 500 VAL A 201 -69.07 -104.67 REMARK 500 ASN A 251 107.07 -49.54 REMARK 500 ASN A 263 31.04 -153.79 REMARK 500 PRO A 282 -73.36 -56.56 REMARK 500 ASN A 288 45.55 -93.29 REMARK 500 ASN B 13 30.23 72.93 REMARK 500 ILE B 14 -51.02 -136.54 REMARK 500 ASP B 69 -66.11 -147.81 REMARK 500 LEU B 126 18.78 -143.40 REMARK 500 LEU B 191 -81.86 -135.11 REMARK 500 LYS B 238 59.79 -91.91 REMARK 500 ILE B 277 32.91 -145.61 REMARK 500 ASN B 288 46.22 -93.27 REMARK 500 ASN B 328 100.39 -172.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TIT A1330 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TIT B1330 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J8J RELATED DB: PDB REMARK 900 A NEW CLASS OF SMALL NON-PEPTIDYL COMPOUNDS BLOCKSPLASMODIUM REMARK 900 FALCIPARUM DEVELOPMENT IN VITRO BY INHIBITINGPLASMEPSINS REMARK 900 RELATED ID: 1LEE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM INCOMPLEX WITH REMARK 900 INHIBITOR RS367 REMARK 900 RELATED ID: 1LF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM INCOMPLEX WITH REMARK 900 INHIBITOR RS370 REMARK 900 RELATED ID: 1LF3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM INCOMPLEX WITH REMARK 900 INHIBITOR EH58 REMARK 900 RELATED ID: 1LF4 RELATED DB: PDB REMARK 900 STRUCTURE OF PLASMEPSIN II REMARK 900 RELATED ID: 1M43 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO2.4 A REMARK 900 RELATED ID: 1ME6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASEFROM REMARK 900 PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED INHIBITOR REMARK 900 RELATED ID: 1PFZ RELATED DB: PDB REMARK 900 PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM REMARK 900 RELATED ID: 1SME RELATED DB: PDB REMARK 900 PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM REMARK 900 FALCIPARUM, IN COMPLEX WITH PEPSTATIN A REMARK 900 RELATED ID: 1W6I RELATED DB: PDB REMARK 900 PLASMEPSIN II-PEPSTATIN A COMPLEX REMARK 900 RELATED ID: 1XDH RELATED DB: PDB REMARK 900 STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A REMARK 900 RELATED ID: 1XE5 RELATED DB: PDB REMARK 900 STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATINANALOGUE REMARK 900 RELATED ID: 1XE6 RELATED DB: PDB REMARK 900 STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATINANALOGUE REMARK 900 RELATED ID: 2BJU RELATED DB: PDB REMARK 900 PLASMEPSIN II COMPLEXED WITH A HIGHLY ACTIVE ACHIRAL INHIBITOR REMARK 900 RELATED ID: 2BL3 RELATED DB: PDB REMARK 900 THEORITICAL INTERACTION MODEL OF PLASMEPSIN II FROM PLASMODIUM REMARK 900 FALCIPARUM WITH A LIGAND FROM AN ECODED STATIN COMBINATORIAL LIBRARY DBREF 1W6H A -1 329 UNP P46925 PLM2_PLAFA 123 453 DBREF 1W6H B -1 329 UNP P46925 PLM2_PLAFA 123 453 SEQRES 1 A 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE SEQRES 2 A 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP SEQRES 3 A 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER SEQRES 4 A 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA SEQRES 5 A 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER SEQRES 6 A 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN SEQRES 7 A 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP SEQRES 8 A 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE SEQRES 9 A 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR SEQRES 10 A 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP SEQRES 11 A 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL SEQRES 12 A 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE SEQRES 13 A 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE SEQRES 14 A 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY SEQRES 15 A 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP SEQRES 16 A 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU SEQRES 17 A 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA SEQRES 18 A 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN SEQRES 19 A 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR SEQRES 20 A 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU SEQRES 21 A 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU SEQRES 22 A 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU SEQRES 23 A 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO SEQRES 24 A 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE SEQRES 25 A 331 THR VAL PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA SEQRES 26 A 331 LEU ALA LYS LYS ASN LEU SEQRES 1 B 331 LEU GLY SER SER ASN ASP ASN ILE GLU LEU VAL ASP PHE SEQRES 2 B 331 GLN ASN ILE MET PHE TYR GLY ASP ALA GLU VAL GLY ASP SEQRES 3 B 331 ASN GLN GLN PRO PHE THR PHE ILE LEU ASP THR GLY SER SEQRES 4 B 331 ALA ASN LEU TRP VAL PRO SER VAL LYS CYS THR THR ALA SEQRES 5 B 331 GLY CYS LEU THR LYS HIS LEU TYR ASP SER SER LYS SER SEQRES 6 B 331 ARG THR TYR GLU LYS ASP GLY THR LYS VAL GLU MET ASN SEQRES 7 B 331 TYR VAL SER GLY THR VAL SER GLY PHE PHE SER LYS ASP SEQRES 8 B 331 LEU VAL THR VAL GLY ASN LEU SER LEU PRO TYR LYS PHE SEQRES 9 B 331 ILE GLU VAL ILE ASP THR ASN GLY PHE GLU PRO THR TYR SEQRES 10 B 331 THR ALA SER THR PHE ASP GLY ILE LEU GLY LEU GLY TRP SEQRES 11 B 331 LYS ASP LEU SER ILE GLY SER VAL ASP PRO ILE VAL VAL SEQRES 12 B 331 GLU LEU LYS ASN GLN ASN LYS ILE GLU ASN ALA LEU PHE SEQRES 13 B 331 THR PHE TYR LEU PRO VAL HIS ASP LYS HIS THR GLY PHE SEQRES 14 B 331 LEU THR ILE GLY GLY ILE GLU GLU ARG PHE TYR GLU GLY SEQRES 15 B 331 PRO LEU THR TYR GLU LYS LEU ASN HIS ASP LEU TYR TRP SEQRES 16 B 331 GLN ILE THR LEU ASP ALA HIS VAL GLY ASN ILE MET LEU SEQRES 17 B 331 GLU LYS ALA ASN CYS ILE VAL ASP SER GLY THR SER ALA SEQRES 18 B 331 ILE THR VAL PRO THR ASP PHE LEU ASN LYS MET LEU GLN SEQRES 19 B 331 ASN LEU ASP VAL ILE LYS VAL PRO PHE LEU PRO PHE TYR SEQRES 20 B 331 VAL THR LEU CYS ASN ASN SER LYS LEU PRO THR PHE GLU SEQRES 21 B 331 PHE THR SER GLU ASN GLY LYS TYR THR LEU GLU PRO GLU SEQRES 22 B 331 TYR TYR LEU GLN HIS ILE GLU ASP VAL GLY PRO GLY LEU SEQRES 23 B 331 CYS MET LEU ASN ILE ILE GLY LEU ASP PHE PRO VAL PRO SEQRES 24 B 331 THR PHE ILE LEU GLY ASP PRO PHE MET ARG LYS TYR PHE SEQRES 25 B 331 THR VAL PHE ASP TYR ASP ASN HIS SER VAL GLY ILE ALA SEQRES 26 B 331 LEU ALA LYS LYS ASN LEU HET TIT A1330 46 HET TIT B1330 46 HETNAM TIT N-((3S,4S)-5-[(4-BROMOBENZYL)OXY]-3-HYDROXY-4-{[N- HETNAM 2 TIT (PYRIDIN-2-YLCARBONYL)-L-VALYL]AMINO}PENTANOYL)-L- HETNAM 3 TIT ALANYL-L-LEUCINAMIDE FORMUL 3 TIT 2(C32 H45 BR N6 O7) FORMUL 5 HOH *230(H2 O) HELIX 1 1 THR A 49 LYS A 55 5 7 HELIX 2 2 ASP A 59 SER A 63 5 5 HELIX 3 3 THR A 108 GLU A 112 5 5 HELIX 4 4 PRO A 113 SER A 118 1 6 HELIX 5 5 TRP A 128 SER A 132 5 5 HELIX 6 6 PRO A 138 GLN A 146 1 9 HELIX 7 7 GLU A 174 ARG A 176 5 3 HELIX 8 8 PRO A 223 GLN A 232 1 10 HELIX 9 9 GLU A 269 TYR A 273 1 5 HELIX 10 10 GLY A 302 LYS A 308 1 7 HELIX 11 11 THR B 49 LYS B 55 5 7 HELIX 12 12 ASP B 59 SER B 63 5 5 HELIX 13 13 THR B 108 GLU B 112 5 5 HELIX 14 14 PRO B 113 SER B 118 1 6 HELIX 15 15 TRP B 128 SER B 132 5 5 HELIX 16 16 PRO B 138 GLN B 146 1 9 HELIX 17 17 GLU B 174 ARG B 176 5 3 HELIX 18 18 PRO B 223 GLN B 232 1 10 HELIX 19 19 GLU B 269 TYR B 273 1 5 HELIX 20 20 GLY B 302 LYS B 308 1 7 SHEET 1 AA 3 LYS A 72 TYR A 77 0 SHEET 2 AA 3 GLY A 80 VAL A 93 -1 O GLY A 80 N TYR A 77 SHEET 3 AA 3 MET A 15 VAL A 22 -1 O GLU A 21 N THR A 92 SHEET 1 AB 7 LYS A 72 TYR A 77 0 SHEET 2 AB 7 GLY A 80 VAL A 93 -1 O GLY A 80 N TYR A 77 SHEET 3 AB 7 LEU A 96 ASP A 107 -1 O LEU A 96 N VAL A 93 SHEET 4 AB 7 LEU A 40 PRO A 43 1 O LEU A 40 N ILE A 103 SHEET 5 AB 7 GLY A 122 GLY A 125 -1 O ILE A 123 N TRP A 41 SHEET 6 AB 7 GLN A 27 ASP A 34 1 O ILE A 32 N LEU A 124 SHEET 7 AB 7 MET A 15 VAL A 22 -1 O GLY A 18 N PHE A 31 SHEET 1 AC 4 ILE A 237 LYS A 238 0 SHEET 2 AC 4 TYR A 245 LEU A 248 -1 O VAL A 246 N ILE A 237 SHEET 3 AC 4 LEU A 284 LEU A 287 -1 O CYS A 285 N THR A 247 SHEET 4 AC 4 LEU A 274 HIS A 276 -1 O GLN A 275 N MET A 286 SHEET 1 BA 3 LYS B 72 TYR B 77 0 SHEET 2 BA 3 GLY B 80 VAL B 93 -1 O GLY B 80 N TYR B 77 SHEET 3 BA 3 MET B 15 VAL B 22 -1 O GLU B 21 N THR B 92 SHEET 1 BB 7 LYS B 72 TYR B 77 0 SHEET 2 BB 7 GLY B 80 VAL B 93 -1 O GLY B 80 N TYR B 77 SHEET 3 BB 7 LEU B 96 ASP B 107 -1 O LEU B 96 N VAL B 93 SHEET 4 BB 7 LEU B 40 PRO B 43 1 O LEU B 40 N ILE B 103 SHEET 5 BB 7 GLY B 122 GLY B 125 -1 O ILE B 123 N TRP B 41 SHEET 6 BB 7 GLN B 27 ASP B 34 1 O ILE B 32 N LEU B 124 SHEET 7 BB 7 MET B 15 VAL B 22 -1 O GLY B 18 N PHE B 31 SHEET 1 BC 7 LYS B 265 LEU B 268 0 SHEET 2 BC 7 PHE B 257 THR B 260 -1 O PHE B 257 N LEU B 268 SHEET 3 BC 7 GLN B 194 HIS B 200 -1 O ASP B 198 N THR B 260 SHEET 4 BC 7 MET B 205 VAL B 213 -1 O LEU B 206 N ALA B 199 SHEET 5 BC 7 THR B 298 LEU B 301 1 O PHE B 299 N ILE B 212 SHEET 6 BC 7 ILE B 220 VAL B 222 -1 O THR B 221 N ILE B 300 SHEET 7 BC 7 ILE B 289 GLY B 291 1 O ILE B 290 N VAL B 222 SHEET 1 BD 4 VAL B 236 ILE B 237 0 SHEET 2 BD 4 VAL B 246 LEU B 248 -1 O VAL B 246 N ILE B 237 SHEET 3 BD 4 LEU B 284 LEU B 287 -1 O CYS B 285 N THR B 247 SHEET 4 BD 4 LEU B 274 HIS B 276 -1 O GLN B 275 N MET B 286 SSBOND 1 CYS A 47 CYS A 52 1555 1555 2.06 SSBOND 2 CYS A 249 CYS A 285 1555 1555 2.04 SSBOND 3 CYS B 47 CYS B 52 1555 1555 2.07 SSBOND 4 CYS B 249 CYS B 285 1555 1555 2.05 CISPEP 1 GLU A 112 PRO A 113 0 1.69 CISPEP 2 GLU B 112 PRO B 113 0 0.34 SITE 1 AC1 16 ILE A 32 ASP A 34 GLY A 36 SER A 37 SITE 2 AC1 16 ASN A 76 TYR A 77 VAL A 78 SER A 79 SITE 3 AC1 16 PHE A 111 THR A 114 PHE A 120 TYR A 192 SITE 4 AC1 16 ASP A 214 GLY A 216 THR A 217 SER A 218 SITE 1 AC2 14 ASP B 34 GLY B 36 SER B 37 ASN B 76 SITE 2 AC2 14 TYR B 77 VAL B 78 SER B 79 PHE B 111 SITE 3 AC2 14 THR B 114 TYR B 192 ASP B 214 GLY B 216 SITE 4 AC2 14 THR B 217 SER B 218 CRYST1 44.210 77.614 84.237 90.00 90.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022619 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012884 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011871 0.00000